Literature DB >> 9710217

Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment.

A Limmer1, T Sacher, J Alferink, M Kretschmar, G Schönrich, T Nichterlein, B Arnold, G J Hämmerling.   

Abstract

Peripheral tolerance is considered to be a safeguard against autoimmunity. Using a TCR-transgenic mouse system displaying peripheral tolerance against a liver-specific MHC class I Kb antigen, we investigated whether the breaking of tolerance would result in autoimmunity. Reversal of tolerance was achieved by simultaneous challenge with cells expressing the Kb autoantigen and IL-2. Tolerance could not be broken with IL-2 alone or when Kb- and IL-2-expressing cells were applied to different sites of the mice. However, despite the presence of activated autoreactive T cells that were able to reject Kb-positive grafts no autoaggression against the Kb-positive liver was observed. These results indicate that breaking of tolerance per se is not sufficient to cause liver-specific autoimmunity. However, when in addition to breaking tolerance the mice were infected with a liver-specific pathogen, autoaggression occurred. Thus, in this system at least two independent steps seem to be required for organ-specific autoimmunity: reversal of peripheral tolerance resulting in functional activation of autoreactive T cells and conditioning of the liver microenvironment which enables the activated T cells to cause tissue damage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710217     DOI: 10.1002/(SICI)1521-4141(199808)28:08<2395::AID-IMMU2395>3.0.CO;2-D

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  29 in total

Review 1.  Maintenance and loss of self-tolerance in B cells.

Authors:  A Iglesias
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 2.  Immune escape by hepatitis B viruses.

Authors:  U Protzer; H Schaller
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

Review 3.  Stimulation of autoimmunity by toll-like receptor ligands.

Authors:  A Limmer; R Ganss; N Garbi; B Arnold; G J Hämmerling
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

4.  Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling.

Authors:  Karl S Lang; Panco Georgiev; Mike Recher; Alexander A Navarini; Andreas Bergthaler; Mathias Heikenwalder; Nicola L Harris; Tobias Junt; Bernhard Odermatt; Pierre-Alain Clavien; Hanspeter Pircher; Shizuo Akira; Hans Hengartner; Rolf M Zinkernagel
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

5.  Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP 1-10 covalently bound to the MHC class II molecule I-Au.

Authors:  Florian C Kurschus; Thilo Oelert; Birgit Liliensiek; Pascale Buchmann; David C Wraith; Günter J Hämmerling; Bernd Arnold
Journal:  Int Immunol       Date:  2005-12-16       Impact factor: 4.823

6.  Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs.

Authors:  Stefan Lüth; Samuel Huber; Christoph Schramm; Thorsten Buch; Stefan Zander; Christine Stadelmann; Wolfgang Brück; David C Wraith; Johannes Herkel; Ansgar W Lohse
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 7.  Pathogens and autoimmune hepatitis.

Authors:  U Christen; E Hintermann
Journal:  Clin Exp Immunol       Date:  2018-10-07       Impact factor: 4.330

8.  Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.

Authors:  J Satoi; K Murata; M Lechmann; E Manickan; Z Zhang; H Wedemeyer; B Rehermann; T J Liang
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

9.  Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance.

Authors:  Gerald Willimsky; Karin Schmidt; Christoph Loddenkemper; Johanna Gellermann; Thomas Blankenstein
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

10.  DNA fusion gene vaccination mobilizes effective anti-leukemic cytotoxic T lymphocytes from a tolerized repertoire.

Authors:  Jason Rice; Michelle L Dossett; Claes Ohlén; Sarah L Buchan; Timothy J Kendall; Stuart N Dunn; Freda K Stevenson; Philip D Greenberg
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.